Last reviewed · How we verify
NCT04509817
Acupuncture for Oligomenorrhea Due to Polycystic Ovary Syndrome
NA trial testing Acupuncture+Usual care in Polycystic Ovary Syndrome in 60 participants. Status unknown.
31 December 2021
Quick facts
| Lead sponsor | China Academy of Chinese Medical Sciences |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 November 2020 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 March 2022 |
| Sites | 3 locations across China, South Korea |
Drugs / interventions tested
- Acupuncture+Usual care
- Usual care
Conditions studied
- Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →
- Oligomenorrhea — all drugs for Oligomenorrhea →
Sponsor
China Academy of Chinese Medical Sciences — full company profile →
Who can join
Adults 20 to 40, female only, with Polycystic Ovary Syndrome or Oligomenorrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is an international multicenter, pilot randomized, assessor-blind, controlled trial, which is aimed to preliminarily investigate the efficacy and safety of acupuncture on oligomenorrhea due to polycystic ovary syndrome (PCOS).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy and safety of acupuncture on oligomenorrhea due to polycystic ovary syndrome: An international multicenter, pilot randomized controlled trial.
Park KS, Gang W, Kim PW, Yang C, et al · · 2022 · cited 4× · PMID 35363161 · DOI 10.1097/md.0000000000028674
Verify or expand the search:
- PubMed search for NCT04509817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polycystic Ovary Syndrome
Currently open trials in the same condition.
- NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
- NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
- NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
- NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
- NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting
Other China Academy of Chinese Medical Sciences trials
Trials by the same sponsor.
- NCT07319338 — Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis · not yet recruiting
- NCT06874738 — A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills · not yet recruiting
- NCT05586048 — Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure · unknown
- NCT05138965 — the Method of Cotton Padding Promoting the Rectovaginal Fistula Surgery · completed
- NCT04932395 — Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04509817 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China Academy of Chinese Medical Sciences
- Last refreshed: 29 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04509817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing